menu toggle

FormularyDecisions for health systems

Connect with the evidence you need for more efficient formulary decision-making

Join the largest active online community of healthcare decision-makers.
pharmacist at computer
professionals around computer monitor

Access information to support formulary decisions

FormularyDecisions is a secure online platform that facilitates the exchange of information between healthcare decision-makers and life sciences companies to provide healthcare decision-makers with the evidence, resources, and tools to support the product evaluation process.
professionals discussing around computer

Acquire product information early

Enhance the way you gather product data via a single, secure platform, available to you, 24/7. There are over 3,000 FDA-approved and pipeline products on the platform. Gain compliant access to the most critical information when considering formulary decisions. In addition, there are over 1 million evidence links to leading scientific resources including the FDA, CDC, NIH, JAMA, PubMed, and more—offering you a more efficient method to source information in support of your product needs.

Evaluate competitive evidence

With FormularyDecisions, you can quickly compare multiple products within a product class. Drug Class Reviews are available to compare indications, mechanisms of action, dosing, and adverse events for similar agents.
pharmacist looking at monitor

Understand the US biosimilar market and laws governing every state

Gain centralized access to all pertinent biosimilar information in the US through the Biosimilars Resource Hub. The hub provides FDA guidance on biosimilars, manufacturer resources, and serves as an exclusive repository for substitution laws for all 50 states.
professionals around computer monitor

Connect with manufacturers

More than 500 manufacturers (pharma, biotech, medical device) are featured on the platform providing information that includes disease and therapeutic information, abstracts, posters, monographs, and pivotal clinical studies. eDossiers allow users to automatically access manufacturer product information once it becomes available and easily create customized product monographs.

White paper

Are US payers getting to grips with cost-effectiveness analysis?

Cost-effectiveness analysis (CEA) is widely used in many countries as part of the broader approach to the health technology assessment (HTA) decision process. It’s common in countries with a national or asocial health insurance system where there is a single payer making decisions for the larger population. In the US, with the multi-payer system, the process is more complex and interpretation expertise of CEAs may vary, making CEA utilization among payers limited.

Xcenda’s FormularyDecision team conducted a study to assess the current use of CEAs by US decision-makers, the challenges that they currently face in using CEAs, and the ways in which these could resolved.

See it in action

Ready to get started?